Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Jan. 30, 2022	Jan. 31, 2021
Cash flows from operating activities:
Net income	$ 31,726	$ 9,509
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	20,810	23,724
Share-based compensation	1,457	1,301
Changes in assets and liabilities:
Accounts receivable	3,269	(2,011)
Inventories	(7,020)	2,095
Other current assets	(6,730)	(824)
Accounts payable, accrued liabilities, and other	15,618	(7,507)
Net cash provided by operating activities	59,130	26,287
Cash flows from investing activities:
Purchases of property, plant and equipment	(19,175)	(17,532)
Government incentives	0	397
Other	(43)	(61)
Net cash used in investing activities	(19,218)	(17,196)
Cash flows from financing activities:
Repayments of debt	(15,192)	(7,796)
Purchases of treasury stock	(2,522)	(13,209)
Contribution from noncontrolling interest	14,997	0
Proceeds from debt	0	6,205
Proceeds from share-based arrangements	3,840	765
Net settlements of restricted stock awards	(1,458)	(315)
Net cash used in financing activities	(335)	(14,350)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash	(2,057)	5,195
Net increase (decrease) in cash, cash equivalents, and restricted cash	37,520	(64)
Cash, cash equivalents, and restricted cash at beginning of period	279,680	281,602
Cash, cash equivalents, and restricted cash at end of period	317,200	281,538
Less: Ending restricted cash	3,005	2,999
Cash and cash equivalents at end of period	314,195	278,539
Supplemental disclosure of non-cash information:
Accruals for property, plant and equipment purchased during the period	$ 7,092	$ 4,938